Nathaniel G N Milton Selected Research

Nathaniel G N Milton Research Topics

9	Alzheimer Disease (Alzheimer's Disease) 07/2020 - 04/2002
4	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2021 - 01/2004
4	Neuroblastoma 07/2020 - 01/2012
2	Parkinson Disease (Parkinson's Disease) 07/2020 - 01/2019
2	Teratocarcinoma 10/2002 - 04/2002
1	Ovarian Neoplasms (Ovarian Cancer) 02/2022
1	Neoplasm Metastasis (Metastasis) 02/2022
1	Neoplasms (Cancer) 07/2020
1	Stroke (Strokes) 07/2020
1	Spinal Cord Injuries (Spinal Cord Injury) 07/2020
1	Neuralgia (Stump Neuralgia) 01/2019
1	Dementia (Dementias) 11/2013
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 11/2013
1	familial Danish Dementia 11/2013
1	Type 2 Diabetes Mellitus (MODY) 11/2013
1	Tauopathies 01/2010
1	Atherosclerosis 01/2010

6	Peptides (Polypeptides)IBA 02/2022 - 04/2002
4	Amyloid beta-PeptidesIBA 01/2005 - 04/2002
3	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2004
2	KisspeptinsIBA 02/2022 - 01/2013
2	Amyloid (Amyloid Fibrils)IBA 11/2013 - 01/2013
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2010 - 01/2004
2	EnzymesIBA 01/2004 - 04/2002
1	Amyloidogenic ProteinsIBA 03/2021
1	DisulfidesIBA 03/2021
1	LigandsIBA 07/2020
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Monoclonal AntibodiesIBA 07/2014
1	Nuclear Proteins (Protein, Nuclear)IBA 07/2014
1	polyhistidineIBA 07/2014
1	Histidine (L-Histidine)FDA Link 07/2014
1	CatalaseIBA 11/2013
1	Adenosine Monophosphate (AMP)IBA 01/2012
1	neuropeptide FF receptorIBA 01/2012
1	ColforsinIBA 01/2012
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2012
1	Protein Isoforms (Isoforms)IBA 01/2010
1	CholesterolIBA 01/2010
1	ApolipoproteinsIBA 01/2010
1	Apolipoprotein E4IBA 01/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2010
1	LipidsIBA 01/2004
1	IronIBA 01/2004
1	DNA (Deoxyribonucleic Acid)IBA 01/2004
1	Heavy MetalsIBA 01/2004
1	CopperIBA 01/2004
1	noladin etherIBA 10/2002
1	anandamide (arachidonylethanolamide)IBA 10/2002
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2002
1	olomoucineIBA 04/2002

6	Therapeutics 02/2022 - 01/2004